TABLE 1

Characteristics of clinical C. auris strains used in the in vivo studies

StrainCountry of originGrowth in untreated controls (log10 CFU/kidneys)In vitro MIC (mg/liter)
RezafunginFluconazoleMicafunginAmphotericin B
B11220Japan3.060.0640.1250.38
B11785Colombia3.430.12580.51.5
B11799Colombia3.670.251620.5
B11211aIndia3.17225641.5
  • a With FKS1_HS1_S639F.